Skip to main content
Premium Trial:

Request an Annual Quote

Spyro Mousses, John Hogenesch, Natasha Caplen, Lucas Pelkmans, Rick Brown

Premium

Qiagen has created a high-throughput RNAi user forum open to all scientists, the company said this week.

The forum will be coordinated by Spyro Mousses, director of cancer drug development at Translational Genomics Research Institute; John Hogenesch, professor of neurobiology at the Scripps Research Institute; Natasha Caplen of the Center for Cancer Research at NCI; Carl Novina, assistant professor of cancer immunology and AIDS at Harvard Medical School; and Lucas Pelkmans, assistant professor at the Institute for Molecular Systems Biology at the Swiss Federal Institute of Technology. (See this week's RNAinsider for more information about the user forum.)


MicroCal appointed Rick Brown CEO and president on March 6.

Brown joins MicroCal from Isis Phramaceuticals, where he was vice president of business development for Isis and president of GeneTrove.

MicroCal is a microcalorimeter maker headquarterd in Northampton, Mass.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.